Radnor Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Radnor Capital Management's DGX Position: Q2 2026 in Review
Radnor Capital Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,257 shares worth $266K. The position accounts for 0.04% of the portfolio, ranked #287.
Radnor Capital Management first reported a position in DGX in Q2 2017 and has held it in 19 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Radnor Capital Management held 1,257 shares of Quest Diagnostics worth $266K as of Q2 2026.
- Radnor Capital Management left its Quest Diagnostics share count unchanged in Q2 2026.
- Quest Diagnostics made up 0.04% of Radnor Capital Management's portfolio in Q2 2026, its #287 holding.
- Radnor Capital Management first reported a position in Quest Diagnostics in Q2 2017 and has held it in 19 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.